TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6807693

Group type: EXPERIMENTAL
Intervention: High carbohydrate, high fibre diet (HC)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Low carbohydrate diet (LC)
Number of subjects: 7
Study: 30564856

Group type: EXPERIMENTAL
Intervention: SWI
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: T1w/SWI
Number of subjects: 37

Group type: COMPARATOR
Intervention: T1w
Number of subjects: 37

Group type: COMPARATOR
Intervention: CT (reference standard)
Number of subjects: 37
Study: 26661592

Group type: EXPERIMENTAL
Intervention: Docetaxel, capecitabine, and cisplatin (DXP)
Number of subjects: 46
Study: 27050431

Group type: EXPERIMENTAL
Intervention: Memantine (5 to 20 mg/day; n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (n = 20)
Number of subjects: 40
Study: 25234932

Group type: EXPERIMENTAL
Intervention: Enhanced care group (faxed medication care plan and follow-up call)
Number of subjects: 945

Group type: COMPARATOR
Intervention: Minimal care group (admission history, medication reconciliation, patient education, discharge medication list, and medication recommendations)
Number of subjects: 945

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 945

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 945
Study: 21659629

Group type: EXPERIMENTAL
Intervention: SCIO‐469 (150, 210, or 300 mg preoperative; 210 mg + 90 mg postoperative)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Ibuprofen (400 mg)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263
Study: 19528368

Group type: EXPERIMENTAL
Intervention: GLP-1 administration
Number of subjects: 8

Group type: COMPARATOR
Intervention: Insulin administration
Number of subjects: 8
Study: 17330056

Group type: EXPERIMENTAL
Intervention: Endurance training programme (12-week treadmill exercise programme, lactate 2.0 mmol/l)
Number of subjects: 52
Study: 15271050

Group type: EXPERIMENTAL
Intervention: Free text CAL tutorial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Didactic CAL tutorial
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (non-CAL users)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Problem-based CAL tutorial
Number of subjects: 0
Study: 11442289

Group type: EXPERIMENTAL
Intervention: Single-breath alkane uptake
Number of subjects: 0
Study: 9516220

Group type: EXPERIMENTAL
Intervention: 200 mg of troglitazone
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: 600 mg of troglitazone
Number of subjects: 350

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 350
Study: 7977117

Group type: EXPERIMENTAL
Intervention: Probucol 0.5 g, twice daily
Number of subjects: 274

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274
Study: 31238920

Group type: EXPERIMENTAL
Intervention: Standardized Patient (SP) module
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Peer Role-Play (RP) module
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control (Baseline)
Number of subjects: 113
Study: 28387007

Group type: EXPERIMENTAL
Intervention: Motivational feedback based on Project CHOICES
Number of subjects: 354

Group type: COMPARATOR
Intervention: Information only
Number of subjects: 354
Study: 25655470

Group type: EXPERIMENTAL
Intervention: ACT-453859 100 mg once a day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACT-453859 800 mg once a day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACT-453859 (dose unspecified)
Number of subjects: 0
Study: 23500234

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 399

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 399
Study: 21223566

Group type: EXPERIMENTAL
Intervention: k‐t BLAST factor of two
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: k‐t BLAST factor greater than two
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: k‐t BLAST
Number of subjects: 0
Study: 18262443

Group type: EXPERIMENTAL
Intervention: Interferential (IF) stimulation followed by patterned muscle stimulation for 15 min and 20 min respectively, treated for 8 weeks
Number of subjects: 116

Group type: COMPARATOR
Intervention: Low-current transcutaneous electrical nerve stimulation (TENS) for 35 min, treated for 8 weeks
Number of subjects: 116
Study: 16873389

Group type: EXPERIMENTAL
Intervention: ANH
Number of subjects: 56
Study: 12554153

Group type: EXPERIMENTAL
Intervention: Gliclazide analysis using HPLC method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Internal standard (phenytoin)
Number of subjects: 0
Study: 10688505

Group type: EXPERIMENTAL
Intervention: Reduced schedule (34, 38, 41 weeks) with home blood pressure monitoring
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard nine subsequent visit schedule (30, 32, 34, 36, 37, 38, 39, 40, 41 weeks)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Reduced schedule with home blood pressure monitoring
Number of subjects: 80
Study: 9110098

Group type: EXPERIMENTAL
Intervention: Scopolamine (4.5 micrograms/kg, IM)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 8409311

Group type: EXPERIMENTAL
Intervention: Eradicating treatment (colloidal bismuth subcitrate plus metronidazole)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Cisapride
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 3752982

Group type: EXPERIMENTAL
Intervention: Novobiocin (500 mg) administered orally, twice a day for 27 doses
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Rifampin (300 mg) administered orally, twice a day for 27 doses
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Novobiocin and rifampin administered in combination
Number of subjects: 10
Study: 30113466

Group type: EXPERIMENTAL
Intervention: Assist‐as‐needed robot‐assisted gait training for the unaffected limb and fully‐assisted robot‐assisted training for the affected limb (Group 1)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Robot‐assisted gait training using the opposite protocol (Group 2)
Number of subjects: 24
Study: 26719212

Group type: EXPERIMENTAL
Intervention: Excess gestational weight gain
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Adequate gestational weight gain
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Inadequate gestational weight gain
Number of subjects: 49
Study: 24996128

Group type: EXPERIMENTAL
Intervention: nab‐paclitaxel (500 mg/100 ml) administered in 6 weekly intravesical instillations
Number of subjects: 28
Study: 22983558

Group type: EXPERIMENTAL
Intervention: eCare (Internet-delivered care management and patient self-management program)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: eCare
Number of subjects: 103

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 103
Study: 20801608

Group type: EXPERIMENTAL
Intervention: Endovenous laser therapy (EVLT) (980 nm)
Number of subjects: 204

Group type: COMPARATOR
Intervention: High ligation and stripping (HL/S)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Endovenous laser therapy (EVLT)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Endovenous laser therapy (EVLT) and High ligation and stripping (HL/S)
Number of subjects: 204
Study: 19247898

Group type: EXPERIMENTAL
Intervention: Intraventricular sodium nitroprusside (SNP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (major systemic illness or did not consent)
Number of subjects: 20
Study: 15831835

Group type: EXPERIMENTAL
Intervention: Targeted subthreshold cortical stimulation guided by fMRI
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Functional MRI (fMRI) guidance
Number of subjects: 12
Study: 12929898

Group type: EXPERIMENTAL
Intervention: CATCH materials in intervention schools
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control schools received training and materials
Number of subjects: 76
Study: 10480957

Group type: EXPERIMENTAL
Intervention: 7.5 mg/kg of rhMnSOD
Number of subjects: 72

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 72
Study: 8735679

Group type: EXPERIMENTAL
Intervention: Intrarectal quinine gluconate (12.8 mg kg‐1)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intramuscular Quinimax (8 mg kg‐1)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intravenous Quinimax (8 mg kg‐1, 4 h infusion)
Number of subjects: 21
Study: 1685090

Group type: EXPERIMENTAL
Intervention: bopindolol 0.5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: bopindolol 1.0 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: bopindolol 2.0 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 7128662

Group type: EXPERIMENTAL
Intervention: Cyclothiazide (2.5 mg daily)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Hydrochlorthiazide-amiloride combination (50 + 5 mg daily)
Number of subjects: 13
Study: 29754654

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (DAPT), n = 527
Number of subjects: 2052

Group type: COMPARATOR
Intervention: Aspirin alone, n = 1525
Number of subjects: 2052
Study: 27275859

Group type: EXPERIMENTAL
Intervention: Continuous high-dose omeprazole infusion for 72 hours
Number of subjects: 305

Group type: COMPARATOR
Intervention: Scheduled second-look endoscopy with intravenous omeprazole bolus every 12 hours for 72 hours
Number of subjects: 305
Study: 24124121

Group type: EXPERIMENTAL
Intervention: Self-affirmation (SA) intervention using a 32-item values affirmation questionnaire
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 22336262

Group type: EXPERIMENTAL
Intervention: Formoterol (extra daily dose inhaled 8 hours after previous dose)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Formoterol t.i.d.
Number of subjects: 56

Group type: COMPARATOR
Intervention: Formoterol b.i.d. + placebo
Number of subjects: 56
Study: 20059698

Group type: EXPERIMENTAL
Intervention: Acotiamide 100 mg t.i.d.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18537181

Group type: EXPERIMENTAL
Intervention: Alpha‐tocopherol 600 IU/day plus ascorbic acid 500 mg/day
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 15918811

Group type: EXPERIMENTAL
Intervention: Expectancy challenge (EC)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Sham alcohol experiment (control)
Number of subjects: 92
Study: 14633947

Group type: EXPERIMENTAL
Intervention: Jejunal gas infusion (12 ml/min for one hour)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Rectal gas infusion (12 ml/min for one hour)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Jejunal gas infusion
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Colonic gas loads
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both jejunal and rectal gas infusion
Number of subjects: 14
Study: 11052956

Group type: EXPERIMENTAL
Intervention: Prior exercise (2 hours at 64 +/- 1% of maximal oxygen uptake)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no prior exercise)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Prior exercise
Number of subjects: 8
Study: 8797120

Group type: EXPERIMENTAL
Intervention: Visual semiquantitative (SQ) assessment by an experienced radiologist
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Visual flagging by research assistants
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Quantitative morphometry (QM) >= 3 SD
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Quantitative morphometry (QM) 15
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Combination assessment of SQ and QM
Number of subjects: 503
Study: 1639992

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulins (individualized doses)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 11
Study: 6702238

Group type: EXPERIMENTAL
Intervention: 10% fat solution containing 50 g/l medium chain triglycerides (MCT) and 50 g/l long chain triglycerides (LCT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 0.9% NaCl
Number of subjects: 18
Study: 30415310

Group type: EXPERIMENTAL
Intervention: Sildenafil (100 mg/day for 3 months)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sildenafil (1 µM)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 27317188

Group type: EXPERIMENTAL
Intervention: Hydrocodone (HYD) 20, 40, 60, 80, or 120 mg once daily
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Hydrocodone (HYD)
Number of subjects: 26
Study: 27653735

Group type: EXPERIMENTAL
Intervention: Incentive plus restriction (30% financial incentive for fruits and vegetables and restriction of purchase of sugar sweetened beverages, sweet baked goods, or candy)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Incentive plus restriction
Number of subjects: 279

Group type: COMPARATOR
Intervention: Control (no incentive or restrictions)
Number of subjects: 279
Study: 24837512

Group type: EXPERIMENTAL
Intervention: MMR SII (aerosol)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: MMR II (aerosol)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: MMR SII (injection)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: MMR II (injection)
Number of subjects: 260
Study: 22484516

Group type: EXPERIMENTAL
Intervention: High sensation seekers
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low sensation seekers
Number of subjects: 40
Study: 19456235

Group type: EXPERIMENTAL
Intervention: Vaginal Lactobacillus colonization
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Yeast identified on wet preparation of vaginal secretions
Number of subjects: 151

Group type: COMPARATOR
Intervention: Bacterial vaginosis
Number of subjects: 151
Study: 17879534

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study: 15735119

Group type: EXPERIMENTAL
Intervention: Ixabepilone (35 mg/m²) alone
Number of subjects: 92

Group type: COMPARATOR
Intervention: Ixabepilone + Estramustine Phosphate (EMP) (280 mg orally three times daily on days 1 to 5)
Number of subjects: 92
Study: 11068226

Group type: EXPERIMENTAL
Intervention: 60 Hz magnetic fields at an occupational intensity (28.3 microTesla)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control condition (< or =0.2 microT)
Number of subjects: 46
Study: 9364263

Group type: EXPERIMENTAL
Intervention: Chlorhexidine and silver-sulfadiazine impregnated catheters (CH-SS)
Number of subjects: 680

Group type: COMPARATOR
Intervention: Non-impregnated catheters
Number of subjects: 680
Study: 1552366

Group type: EXPERIMENTAL
Intervention: Uncooked extreme vegan diet for 1 month
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Conventional diet after vegan diet for 1 month
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional diet throughout the study
Number of subjects: 18
Study: 3907071

Group type: EXPERIMENTAL
Intervention: Gastric aspiration with a wide-bored tube
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fasting for six hours without gastric aspiration
Number of subjects: 40
Study: 31074815

Group type: EXPERIMENTAL
Intervention: Electronic screening and personalized feedback with clinician clinical decision support
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard screening and counseling as provided by their clinic (Control)
Number of subjects: 300
Study: 29064556

Group type: EXPERIMENTAL
Intervention: BITE supervision (live computer‐based supervision during a psychotherapy session)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Delayed video‐based (DVB) supervision
Number of subjects: 42
Study: 26824902

Group type: EXPERIMENTAL
Intervention: Lopimune (Lopinavir/Ritonavir), 1 capsule twice daily for 2 weeks, self-applied as a vaginal pessary
Number of subjects: 23
Study: 24331777

Group type: EXPERIMENTAL
Intervention: Regular exercise and nutritional guidance for 6 months
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 114
Study: 20641031

Group type: COMPARATOR
Intervention: Calcium 1 g/day
Number of subjects: 1794

Group type: COMPARATOR
Intervention: Calcium 600 or 1200 mg/day
Number of subjects: 1794

Group type: COMPARATOR
Intervention: Calcium supplementation
Number of subjects: 1794

Group type: COMPARATOR
Intervention: Calcium intake
Number of subjects: 1794

Group type: COMPARATOR
Intervention: Low bone mineral density (BMD)
Number of subjects: 1794
Study: 19100933

Group type: EXPERIMENTAL
Intervention: Rocuronium (0.06 mg/kg)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 110
Study: 16860974

Group type: EXPERIMENTAL
Intervention: Definition 1 (PANSS items sustained over at least 6 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Definition 2 (BPRS % change, CGI-S threshold score maintained for at least 8 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both definitions (patients meeting threshold criteria at both 24 and 52 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BPRS total % change from baseline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients meeting threshold criteria at the 8-, 16-, or 24-week visits
Number of subjects: 0
Study: 12787711

Group type: EXPERIMENTAL
Intervention: External beam radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiation dose escalation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant hormone therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant radiation following surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypofractionation and dose individualisation
Number of subjects: 0
Study: 11186159

Group type: EXPERIMENTAL
Intervention: Phonemic fluency tests administered individually
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy normal controls
Number of subjects: 0
Study: 8761394

Group type: COMPARATOR
Intervention: Cleansing enema
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Pico-salax
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Golytely
Number of subjects: 150
Study: 1486111

Group type: EXPERIMENTAL
Intervention: Randomized study
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-randomized study
Number of subjects: 0
Study: 3514333

Group type: EXPERIMENTAL
Intervention: sorbinil (250 mg once a day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: sorbinil
Number of subjects: 32
Study: 31897748

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: High-impact exercises
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 58
Study: 29066327

Group type: EXPERIMENTAL
Intervention: Prophylactic vaccine candidate (n = 7)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (n = 5)
Number of subjects: 12
Study: 28086004

Group type: EXPERIMENTAL
Intervention: Montgomery‐Asberg Depression Rating Scale (MADRS) with a 24‐hour recall period (MADRS‐24hr)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: MADRS‐24hr
Number of subjects: 23
Study: 24387663

Group type: EXPERIMENTAL
Intervention: Researcher-completed delivery mode
Number of subjects: 201

Group type: COMPARATOR
Intervention: Self-completed delivery mode
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Patient questionnaires
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Estimated dates from patient questionnaires
Number of subjects: 201
Study: 22751375

Group type: EXPERIMENTAL
Intervention: Formula enriched with fish oil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isocaloric control formula
Number of subjects: 40
Study: 20197658

Group type: EXPERIMENTAL
Intervention: Dietary intervention, energy restricted by 30% for 8 weeks
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Baseline leptin concentrations
Number of subjects: 324

Group type: COMPARATOR
Intervention: Dietary intervention
Number of subjects: 324
Study: 18394859

Group type: EXPERIMENTAL
Intervention: High frequency electrical stimulation of the subthalamic nucleus
Number of subjects: 15

Group type: COMPARATOR
Intervention: Stimulation turned off
Number of subjects: 15
Study: 20015816

Group type: COMPARATOR
Intervention: 0.0625% bupivacaine alone (Group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.0625% bupivacaine + 2 microg/mL fentanyl (Group B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.0625% bupivacaine + 4 microg/mL fentanyl (Group C)
Number of subjects: 60
Study: 16526414

Group type: EXPERIMENTAL
Intervention: Dairy product intake
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 11762412

Group type: EXPERIMENTAL
Intervention: Rituxan (rituximab) in combination with CHOP chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rituxan (rituximab)
Number of subjects: 0
Study: 9394690

Group type: EXPERIMENTAL
Intervention: 1.03 mg vitamin B-6/d
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1.33 mg vitamin B-6/d
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1.73 mg vitamin B-6/d
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 2.39 mg vitamin B-6/d
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 0.84 mg vitamin B-6/d
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1.14 mg vitamin B-6/d
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 2.34 mg vitamin B-6/d
Number of subjects: 16
Study: 8110669

Group type: COMPARATOR
Intervention: Retrobulbar block (group R)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Periocular anaesthesia (group PI)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Periocular anaesthesia (group PII)
Number of subjects: 450
Study: 3828178

Group type: EXPERIMENTAL
Intervention: 4% lignocaine 160 mg using a Forrester Spray
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 4% lignocaine 160 mg by 'Laryng‐o‐jet'
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline administered by Forrester Spray
Number of subjects: 30
Study: 12510954

Group type: EXPERIMENTAL
Intervention: Rivastigmine 6-12 mg/day
Number of subjects: 725

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 725
Study: 30223772

Group type: EXPERIMENTAL
Intervention: Preoperative hand disinfection
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Wearing surgical gloves
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Bacterial growth at glove cuff end
Number of subjects: 25

Group type: COMPARATOR
Intervention: Total colony forming units
Number of subjects: 25
Study: 26679760

Group type: EXPERIMENTAL
Intervention: Risperidone plus T3 (25 μg daily)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Risperidone plus placebo
Number of subjects: 32